Today: 22 March 2026
Browse Category

NASDAQ:IESC 17 December 2025

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings shares fell about 9% to $405 on Dec. 17, 2025, after opening above $446 and hitting an intraday high near $451. The drop followed a multi-year rally and came on lighter-than-usual volume. IES recently reported record fiscal 2025 results, with Q4 revenue up 16% to $898 million and net income up 61% to $101.8 million. Remaining performance obligations stood at $1.69 billion at year-end.

Stock Market Today

  • Abbott Laboratories Valuation Faces Scrutiny Amid Recent Share Price Volatility
    March 22, 2026, 10:19 AM EDT. Abbott Laboratories (ABT) has experienced recent share price weakness, sparking a reassessment of its valuation. Trading at $105.46, the stock shows a 6.02% gain over 30 days but reflects mixed longer-term returns, with a 15.08% year-to-date rise against a modest 5-year total shareholder return of 5.34%. Simply Wall St's analysis estimates a fair value of $113.88, suggesting an approximate 36% intrinsic discount and potential undervaluation. Despite a P/E ratio of 28.3x above the US Medical Equipment industry average, Abbott's strong fundamentals, innovation focus, and diversified portfolio support its position as a growth stock with defensive traits. However, risks include regulatory challenges and margin pressure from costs and competition. Investors should balance these rewards and risks to inform their investment outlook on ABT.
Go toTop